Trial Profile
Effect of bendamustine + rituximab versus rituximab + cyclophosphamide + doxorubicin + vincristine + prednisolone in patients with follicular lymphoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 May 2015
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary) ; Rituximab
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 06 May 2015 New trial record